ES8605513A1 - Un procedimiento para preparar derivados de piridina - Google Patents

Un procedimiento para preparar derivados de piridina

Info

Publication number
ES8605513A1
ES8605513A1 ES543728A ES543728A ES8605513A1 ES 8605513 A1 ES8605513 A1 ES 8605513A1 ES 543728 A ES543728 A ES 543728A ES 543728 A ES543728 A ES 543728A ES 8605513 A1 ES8605513 A1 ES 8605513A1
Authority
ES
Spain
Prior art keywords
alkyl
group
formula
chem
optionally substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES543728A
Other languages
English (en)
Other versions
ES543728A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838322347A external-priority patent/GB8322347D0/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES543728A0 publication Critical patent/ES543728A0/es
Publication of ES8605513A1 publication Critical patent/ES8605513A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

PROCEDIMIENTO PARA PREPARAR DERIVADOS DE PIRIDINA. CONSISTE EN HACER REACCIONAR A UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (B1OB4), EN UN ALCANOL DE C 1 A 6 Y A LA TEMPERATURA DE EBULLICION DE LA MEZCLA DE REACCION, PARA OBTENER UN COMPUESTO DE FORMULA (I) Y SUS SALES FARMACEUTICAMENTE ACEPTABLES. SIENDO: B1, UN GRUPO DESPLAZABLE POR AMINA; B4, NHR10; R1 Y R2, HAL, NITRO AMINO (O UN DERIVADO FARMACEUTICAMENTE ACEPTABLE DEL GRUPO AMINO QUE ES CONVERTIBLE IN VIVO EN AMINO), ALQUILO DE C 1 A 4 Y OTROS; R3, ALQUILENO DE C 1 A 3; R4, UN GRUPO DE FORMULA DR; D, UN GRUPO DE FORMULA (III) O (IV); R10, H, ALQUILO DE C 1 A 6 Y OTROS; R13, R1 O AMINO PROTEGIDO; R14, R2 O AMINO PROTEGIDO; Y N, 0, 1 O 2. SE UTILIZA PARA EL TRATAMIENTO DEL ASMA BRONQUIAL, RINITIS Y FIEBRE DEL HENO.
ES543728A 1982-12-14 1985-05-31 Un procedimiento para preparar derivados de piridina Expired ES8605513A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8235590 1982-12-14
GB838322347A GB8322347D0 (en) 1983-08-19 1983-08-19 Pyridine derivatives

Publications (2)

Publication Number Publication Date
ES543728A0 ES543728A0 (es) 1986-03-16
ES8605513A1 true ES8605513A1 (es) 1986-03-16

Family

ID=26284681

Family Applications (3)

Application Number Title Priority Date Filing Date
ES527994A Granted ES527994A0 (es) 1982-12-14 1983-12-13 Un procedimiento para preparar derivados de piridina.
ES543729A Expired ES8607241A1 (es) 1982-12-14 1985-05-31 Un procedimiento para preparar derivados de piridina
ES543728A Expired ES8605513A1 (es) 1982-12-14 1985-05-31 Un procedimiento para preparar derivados de piridina

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES527994A Granted ES527994A0 (es) 1982-12-14 1983-12-13 Un procedimiento para preparar derivados de piridina.
ES543729A Expired ES8607241A1 (es) 1982-12-14 1985-05-31 Un procedimiento para preparar derivados de piridina

Country Status (8)

Country Link
US (2) US4532252A (es)
EP (1) EP0112142B1 (es)
AU (1) AU2222083A (es)
DE (1) DE3381674D1 (es)
DK (1) DK572583A (es)
ES (3) ES527994A0 (es)
GR (1) GR79163B (es)
PT (1) PT77808B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA832154B (en) * 1982-03-29 1983-12-28 Bristol Myers Co Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2-receptor antagonist activity
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
PT78358B (en) * 1983-04-07 1986-05-30 Smith Kline French Lab Chemical process
US4728648A (en) * 1985-02-09 1988-03-01 Smith Kline & French Laboratories Limited Histamine antagonist triadiazole derivatives, compositions, and method of use therefor
CA1286297C (en) * 1985-06-13 1991-07-16 George S. Sach Pyridine derivatives
GB8610867D0 (en) * 1986-05-02 1986-06-11 Smith Kline French Lab 3-hydroxypyridines
IE71183B1 (en) * 1988-12-27 1997-01-29 Takeda Chemical Industries Ltd Guanidine derivatives their production and insecticides
AU727217B2 (en) * 1996-06-17 2000-12-07 American Home Products Corporation Heterocyclylmethylamino derivatives of cyclobutene-3,4- diones as potassium channel modulators
US5872139A (en) * 1996-06-17 1999-02-16 American Home Products Corporation Heterocyclymethylamino derivatives of cyclobutene-3,4-diones
PE20040570A1 (es) * 2002-10-09 2004-08-30 Pharmacopeia Drug Discovery Tiadiazoldioxidos y tiadiazoloxidos como ligandos del receptor de cxc- y cc-quimiocina
US7338968B2 (en) * 2003-12-19 2008-03-04 Schering Corporation Thiadiazoles AS CXC- and CC- chemokine receptor ligands
TW200530231A (en) * 2003-12-22 2005-09-16 Schering Corp Isothiazole dioxides as CXC-and CC-chemokine receptor ligands
ATE432921T1 (de) * 2004-12-23 2009-06-15 Gpc Biotech Ag Quadratsäurederivate mit antiproliferativer wirkung
WO2007005403A1 (en) * 2005-06-29 2007-01-11 Schering Corporation 5,6-di-substituted oxadiazolopyrazines and thiadiazolopyrazines as cxc-chemokine receptor ligands
CN101253165A (zh) * 2005-06-29 2008-08-27 先灵公司 作为cxc－化学活素受体配体的二取代的二唑
US8450348B2 (en) * 2007-02-21 2013-05-28 Forma Tm, Llc Derivatives of squaric acid with anti-proliferative activity

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535328A (en) * 1967-09-01 1970-10-20 Exxon Research Engineering Co Certain substituted aminothioethoxy pyridines
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
GB1419994A (en) * 1973-05-03 1976-01-07 Smith Kline French Lab Heterocyclicalkylaminotheterocyclic compounds methods for their preparation and compositions comprising them
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
GB1497260A (en) * 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives
IL49528A (en) * 1975-05-21 1980-11-30 Smith Kline French Lab Imidazolyl(or thiazolyl)methylthio(or butyl)guanidine or thiourea derivatives,their preparation and pharmaceutical compositions comprising them
US4120973A (en) * 1975-07-31 1978-10-17 Smithkline & French Laboratories Limited Imidazolyl alkylaminocyclobutenediones
GB1595291A (en) * 1976-09-21 1981-08-12 Smith Kline French Lab Pyrimidone and thiopyrimidone derivatives
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
IL57415A (en) * 1978-05-30 1984-08-31 Smith Kline French Lab Nitropyrrole compounds,process for preparing them and pharmaceutical compositions containing them
IL57416A (en) * 1978-05-30 1983-03-31 Smith Kline French Lab Nitro compounds,processes for preparing them and compositions containing them
US4250316A (en) * 1978-11-24 1981-02-10 Bristol-Myers Company Pyridyl guanidine anti-ulcer agents
US4394508A (en) * 1980-06-07 1983-07-19 Bristol-Myers Company Chemical compounds
US4380639A (en) * 1981-03-03 1983-04-19 Bristol-Myers Company Substituted 1,2,5-thiadiazole derivatives
US4503051A (en) * 1981-05-18 1985-03-05 Bristol-Myers Company Substituted 3-cyclobutene-1,2-diones, pharmaceutical compositions thereof and methods of use
US4390701A (en) * 1981-05-18 1983-06-28 Bristol-Myers Company 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
US4528375A (en) * 1982-03-29 1985-07-09 Bristol-Myers Company Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H2 -receptor antagonist activity
ZA832154B (en) * 1982-03-29 1983-12-28 Bristol Myers Co Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine h2-receptor antagonist activity
GB2131683B (en) * 1982-12-11 1986-03-12 Alma Ruby Skelcher Walking aid foot device
AU2222083A (en) * 1982-12-14 1984-06-21 Smith Kline & French Laboratories Limited Pyridine derivatives
JO1279B1 (en) * 1982-12-23 1985-04-20 جون ايف روبرت Pyridine derivatives
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles

Also Published As

Publication number Publication date
GR79163B (es) 1984-10-02
ES8600245A1 (es) 1985-10-01
EP0112142B1 (en) 1990-06-20
ES543728A0 (es) 1986-03-16
DE3381674D1 (de) 1990-07-26
AU2222083A (en) 1984-06-21
PT77808B (en) 1986-03-26
ES543729A0 (es) 1986-05-16
PT77808A (en) 1984-01-01
US4640926A (en) 1987-02-03
ES8607241A1 (es) 1986-05-16
EP0112142A3 (en) 1986-01-15
DK572583A (da) 1984-06-15
ES527994A0 (es) 1985-10-01
DK572583D0 (da) 1983-12-13
EP0112142A2 (en) 1984-06-27
US4532252A (en) 1985-07-30

Similar Documents

Publication Publication Date Title
ES8607241A1 (es) Un procedimiento para preparar derivados de piridina
RU92004336A (ru) Водорастворимые производные камптотецина, способ их получения, фармацевтическая композиция, способ ингибирования энзима топоизомеразы, промежуточные продукты
FI900613A0 (fi) Menetelmä farmakologisesti aktiivisten heterosyklisten yhdisteiden valmistamiseksi
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
HUT68856A (en) Acridine derivatives, pharmaceutical compositions comprising the same compouds as effective substances and a process for producing the compounds and the pharmaceutical compositions
MY119542A (en) Therapeutic biaryl derivatives
DE68906183D1 (de) 2'-desoxy-5-fluoruridinderivate.
SE0101579D0 (sv) New compounds
AR006619A1 (es) Derivados de aminopiridina, composicion farmaceutica que los contien, metodo para elaborar un medicamento, intermediario quimico para la produccionde dichos compuestos y procedimiento para preparar los derivados de aminopiridina
FR2592879B1 (fr) Nouveaux derives de la decahydroquinoleine, leur procede de preparation, les intermediaires de preparation, leur application a titre de medicaments et les compositions les renfermant
ES8506629A1 (es) Un procedimiento para preparar derivados de piridina
ES8500935A1 (es) Un procedimiento para preparar derivados de piridina.
SE8303913L (sv) Heterocykliska foreningar
ES2001944A6 (es) Procedimiento de obtencion de derivados de xantina con actividad broncodilatadora y antiasmatica.
ES8504768A1 (es) Un procedimiento para preparar derivados de pirimidona
ES8504771A1 (es) Un procedimiento para preparar derivados de piridina
JO1274B1 (en) Pyridine derivatives
FR2479219B1 (es)
DE3070032D1 (en) Aminoalkyl benzofuran derivatives, their production and compositions containing them
EA199900608A1 (ru) Новые ингибиторы фарнезилтрансферазы, способы их получения, содержащие их фармацевтические композиции и их применение для получения медикаментов
FI101071B (fi) Menetelmä terapeuttisesti käyttökelpoisten 3,4-dihydroisokinoliini-N-o ksidien valmistamiseksi
KR860004040A (ko) 3,4-디아졸 유도체의 제조방법
ES8206492A1 (es) Procedimiento de preparacion de derivados 2-metileno-quino- xalino-1,4-dioxidos
ES535795A0 (es) Un procedimiento para preparar nuevas 5-aminometil-imidazol-1-il-1,3-dialquil-1h-pirazol-4-il-aroil-metanonas
ES2076995T3 (es) Procedimiento para preparar derivados de carbamato de lankacidina.